THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

RenovoRx maintains $3. 75M-$4. 25M 2026 revenue guidance as it targets 36 active cancer centers

The development centers on renovoRx maintains $3.75M-$4.25M 2026 revenue guidance as it targets 36 active cancer.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights